Cortellis Clinical Trials Intelligence

Thomson Reuters Cortellis™ Clinical Trials Intelligence provides you with the information needed to evaluate market opportunities, identify potential barriers, and make better informed decisions regarding clinical trial design and operations.

Whether you want to get the basics and get started fast — or fine tune your skills, Thomson Reuters can help with a variety of targeted training opportunities.

For more information about live training requests please email:

Getting Started with Cortellis Clinical Trials Intelligence (30 mins)

Accelerate your clinical development decisions and portfolio strategy with Cortellis Clinical Trials Intelligence. Cortellis offers curated clinical trials information, gathered from multiple sources and international registries. It includes over 250,000 global trials, covering drugs, biologics, medical devices and biomarkers, for all therapeutic areas and rare diseases.

This introductory session will give you an overview of Cortellis Clinical Trials Intelligence and show you how Cortellis can answer questions such as:

  • Where should I run my trials to minimize competition for patients?
  • What endpoints are my competitors going after?
  • Which biomarkers should I use to stratify patients?
  • Were there any adverse effects reported for my condition of interest?

Join us online to learn more about Cortellis Clinical Trials Intelligence in 30 minutes + Q&A.

Thursday, February 2, 2017
10am London – 11am Paris
Tuesday, February 14, 2017
11am New York/ 4pm London/ 5pm Paris